Triple
T2190788
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | alsoKnownAs |
P39
|
FINISHED |
| Object |
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
|
E241393
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88aaba3c48190b351cab9b26989ff |
elicitation | completed |
| NER | batch_69abbf3f5e008190beda3ce5d77209e0 |
ner | completed |
| NED1 | batch_69ae5db0352c8190aa9c4c58460df3a4 |
ned_source_triple | completed |
| NED2 | batch_69ae5ec4a35c8190bffc7a183497e764 |
ned_description | completed |
| NEDg | batch_69ae5e60b45c819088bf18ae564f0d1a |
nedg | completed |
Created at: March 4, 2026, 7:46 p.m.